SCHEMBL19839844

SCHEMBL19839844

COC(=O)[C@H](CCCCNC(=O)OC(C)(C)C)NCc1ccc(-c2ccccc2)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 5/20 0.51
▸ NPSR1 Q6W5P4 5/20 0.51
▸ MEN1 O00255 4/20 0.51
▸ KMT2A Q03164 4/20 0.51
▸ CA1 P00915 2/20 0.50
▸ CA2 P00918 2/20 0.50
▸ POLB P06746 2/20 0.49
▸ TDP1 Q9NUW8 3/20 0.47
▸ PAX8 Q06710 2/20 0.47
▸ CTSK P43235 2/20 0.47
▸ HDAC1 Q13547 1/20 0.46
▸ KDM4E B2RXH2 2/20 0.46
▸ GLA P06280 1/20 0.46
▸ GAA P10253 1/20 0.46
▸ ALDH1A1 P00352 1/20 0.45
▸ TLR2 O60603 1/20 0.45
▸ CTSS P25774 1/20 0.45
▸ ABCB1 P08183 1/20 0.45
▸ MMP2 P08253 1/20 0.45
▸ MMP9 P14780 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19839847 1.00 MAPT (0.51) MAPTNPSR1MEN1KMT2ACA1
SCHEMBL19839791 0.91 CA1 (0.52) MAPTNPSR1MEN1KMT2ACA1
SCHEMBL19839794 0.91 CA1 (0.52) MAPTNPSR1MEN1KMT2ACA1
SCHEMBL19839686 0.85 MEN1 (0.55) MAPTNPSR1MEN1KMT2ACA1
SCHEMBL19839675 0.85 MEN1 (0.55) MAPTNPSR1MEN1KMT2ACA1
SCHEMBL19839673 0.85 MEN1 (0.55) MAPTNPSR1MEN1KMT2ACA1
SCHEMBL10424905 0.84 MAPT (0.54) MAPTNPSR1MEN1KMT2ACA1
SCHEMBL15199987 0.83 CTSK (0.44) MAPTMEN1KMT2ACA1CA2
SCHEMBL8091300 0.83 MAPT (0.61) MAPTCA1CA2ABCB1MMP2
SCHEMBL8083532 0.83 MAPT (0.61) MAPTCA1CA2ABCB1MMP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3493814-A1 LIPID-SUBSTITUTED AMINO 1,2-AND 1,3-DIOL COMPOUNDS AS MODULATORS OF TLR2 DIMERIZATION Neuropore Therapies, Inc. (US) 2019-06-12 — — EP disclosed
WO-2018026866-A1 LIPID-SUBSTITUTED AMINO 1,2-AND 1,3-DIOL COMPOUNDS AS MODULATORS OF TLR2 DIMERIZATION NEUROPORE THERAPIES, INC. (US) 2018-02-08 — — WO disclosed
Send feedback